Huntington National Bank Immunity Bio, Inc. Transaction History

Huntington National Bank

  • $14.8 Billion
  • Q2 2025

A detailed history of Huntington National Bank transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Huntington National Bank holds 1,625 shares of IBRX stock, worth $3,835. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,625
Holding current value
$3,835
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025
BUY
$1.89 - $3.44 $3,071 - $5,590
1,625 New
1,625 $4,000

About ImmunityBio, Inc.

IBRX Quotes by TradingView
  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $945M
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email